Author

Ye Mou

Kunming Medical University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:genetic perturbation / CRISPR· 2 Organism:plant (other)· 2 Assay:whole-genome sequencing· 2 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Cheng LiuiD· 2 shared Gongchao YangiD· 2 shared Liwang CuiiD· 2 shared Maohua Pan· 2 shared Mengxi Duan· 2 shared Tao Liang· 2 shared Weilin Zeng· 2 shared Xiuya Tang· 2 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Cheng LiuORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Association study of Plasmodium falciparum Acetyl-CoA Synthetase Mutations S868G and V949I with antimalarial drugs

Wei Xia Zhao, Zheng Xiang, Weilin Zeng, Yucheng Qin, Maohua Pan, Yanrui Wu, Mengxi Duan, Ye Mou, Tao Liang, Yanmei Zhang, Cheng Liu, Xiuya Tang, Yaming Huang, Gongchao Yang, Liwang Cui, Zhaoqing Yang

This study investigates the association of PfACAS mutations S868G and V949I with antimalarial drug resistance using whole-genome sequencing and CRISPR/Cas9-engineered parasites.

bioRxiv · Jul 10, 2024 · PreprintMicrobiology

Acetyl-CoA Synthetase Mutations S868G and V949I Do Not Confer Resistance to Antimalarial Drugs in vitro in Plasmodium falciparum.

Wei Zhao, Zheng Xiang, Weilin Zeng, Yucheng Qin, Maohua Pan, Yanrui Wu, Mengxi Duan, Ye Mou, Tao Liang, Yanmei Zhang, Cheng Liu, Xiuya Tang, Yaming Huang, Gongchao Yang, Liwang Cui, Zhaoqing Yang

This study investigates whether mutations in PfACAS confer antimalarial drug resistance by engineering parasite lines with these mutations and testing their drug susceptibility in vitro.

bioRxiv · Jun 3, 2024 · PreprintMicrobiology